Clinical Trial Update: Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing atazanavir to lopinavir/ritonavir in HIV-infected patients who have not had success with protease inhibitor-containing regime…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 3 | Status: COMPLETED